The role of central neck dissection and adjuvant treatment in pT4aN0 laryngeal carcinoma treated with open partial horizontal laryngectomy.

Adjuvant radiotherapy Advanced stage Laryngeal carcinoma Neck dissection Open partial horizontal laryngectomy

Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
08 Jul 2024
Historique:
received: 26 12 2023
accepted: 18 06 2024
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 8 7 2024
Statut: aheadofprint

Résumé

The study aimed to identify parameters that could predict oncological and functional outcomes in patients with pT4aN0 laryngeal squamous cell carcinoma (LSCC) who underwent open partial horizontal laryngectomy (OPHL). The role of paratracheal neck dissection (PTND) was analyzed as the primary outcome. Additionally, the study compared the outcomes of patients who underwent postoperative radio/chemotherapy (PORT/PORCT) with those who refused or did not adhere to adjuvant treatments. Twenty-nine OPHL patients whose pathological exam was consistent with pT4aN0-x disease were enrolled and their clinical charts were retrospectively reviewed. The study analyzed oncological outcomes, such as local, regional, and distant recurrence rates (RR), overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS). Additionally, functional results were analyzed, including decannulation rate, hospitalization time, and postoperative complication rate. The study revealed and overall recurrence rate of 27%. The final rates for OS and DSS were 68% and 79%, respectively. Based on the univariate analysis the PTND was significantly associated with longer DFS. No significant differences inoncological outcomes were observed between pT4a patients who underwent adjuvant radio/radiochemotherapy and those who did not, in terms of RR, DFS, DSS or OS. However, adjuvant treatment was found to significantly increase decannulation time. In a properly super-selected subgroup of patients with pT4aN0 LSCC, OPHL may beconsidered as a conservative surgical option even without adjuvant treatment. However, for optimal oncological outcomes, it is strongly recommended to consider a central compartment dissection in cases of hypoglottic and anterior extra-laryngeal tumor extension.

Identifiants

pubmed: 38977487
doi: 10.1007/s00405-024-08799-3
pii: 10.1007/s00405-024-08799-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Department of Veterans Affairs Laryngeal Cancer Study Group, Wolf GT, Fisher SG et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690. https://doi.org/10.1056/NEJM199106133242402
doi: 10.1056/NEJM199106133242402
Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098. https://doi.org/10.1056/NEJMoa031317
doi: 10.1056/NEJMoa031317 pubmed: 14645636
Succo G, Crosetti E, Bertolin A et al (2018) Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: prognostic impact of different pathologic tumor subcategories. Head Neck Sep 40(9):1897–1908. https://doi.org/10.1002/hed.25176
doi: 10.1002/hed.25176
Schroeder U, Wollenberg B, Bruchhage KL (2015) The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)]. HNO 63(11):741–746. https://doi.org/10.1007/s00106-015-0071-0
doi: 10.1007/s00106-015-0071-0 pubmed: 26452490
National Comprehensive Cancer Network (NCCN) (2024) Clinical Practice Guidelines in Oncology (NCCN Guidelines
Lucioni M, D’Ascanio L, De Nardi E et al (2018) Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement. Head Neck 40(1):24–33. https://doi.org/10.1002/hed.24905
doi: 10.1002/hed.24905 pubmed: 28960661
Deganello A, Ruaro A, Gualtieri T et al (2023) Central Compartment Neck Dissection in Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Clinical Considerations. Cancers (Basel). 28;15(3):804. https://doi.org/10.3390/cancers15030804
Medina JE, Ferlito A, Robbins KT et al (2011) Central compartment dissection in laryngeal cancer. Head Neck 33(5):746–752. https://doi.org/10.1002/hed.21453
doi: 10.1002/hed.21453 pubmed: 20652888
Chabrillac E, Jackson R, Mattei P et al (2022) Paratracheal lymph node dissection during total (pharyngo-)laryngectomy: a systematic review and meta-analysis. Oral Oncol 132:106017
doi: 10.1016/j.oraloncology.2022.106017 pubmed: 35830760
Succo G, Peretti G, Piazza C et al (2014) Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society. Eur Arch Otorhinolaryngol 271:2489–2496. https://doi.org/10.1007/s00405-014-3024-4
doi: 10.1007/s00405-014-3024-4 pubmed: 24691854
Simo R, Bradley P, Chevalier D et al (2014) European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol 271(9):2469–2479. https://doi.org/10.1007/s00405-014-2966-x
doi: 10.1007/s00405-014-2966-x pubmed: 24609733
Dziegielewski PT, O’Connell DA, Klein M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 41(Suppl 1):S56–S64
pubmed: 22569051
Megwalu UC, Sikora AG (2014) Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Neck Surg 140(9):855–860. https://doi.org/10.1001/jamaoto.2014.1671
doi: 10.1001/jamaoto.2014.1671
Vengalil S, Giuliani ME, Huang SH et al (2016) Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy. Head Neck 38(Suppl 1):E2035–E2040. https://doi.org/10.1002/hed.24374
doi: 10.1002/hed.24374 pubmed: 26828197
Gill AS, Said M, Tollefson TT, Steele TO (2019) Update on empty nose syndrome: disease mechanisms, diagnostic tools, and treatment strategies. Curr Opin Otolaryngol Head Neck Surg 27(4):237–242. https://doi.org/10.1097/MOO.0000000000000544
doi: 10.1097/MOO.0000000000000544 pubmed: 31116142
Marchi F, Missale F, Sampieri C et al (2020) Laryngeal compartmentalization does not affect the prognosis of T3-T4 laryngeal cancer treated by upfront total laryngectomy. Cancer 12(8):2241. https://doi.org/10.3390/cancers12082241
doi: 10.3390/cancers12082241
Grover S, Swisher-McClure S, Mitra N et al (2015) Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol 92(3):594–601. https://doi.org/10.1016/j.ijrobp.2015.03.004
doi: 10.1016/j.ijrobp.2015.03.004
de Vincentiis M, Greco A, Campo F et al (2022) Open partial horizontal laryngectomy for T2-T3-T4a laryngeal cancer: oncological outcomes and prognostic factors of two Italian hospitals. Eur Arch Otorhinolaryngol 279(6):2997–3004. https://doi.org/10.1007/s00405-021-07238-x
doi: 10.1007/s00405-021-07238-x pubmed: 34978589
Succo G, Bertolin A, Santos IC et al (2023) Partial laryngectomy for pT4a laryngeal Cancer: outcomes and limits in selected cases. Cancers 2023,15,2861 https://doi.org/10.3390/cancers15102861
Tsushima N, Hayashi R, Shinozaki T, Tomioka T, Okano W, Ikeda M (2019) The role of elective neck dissection for cT4aN0 glottic squamous cell carcinoma. Jpn J Clin Oncol. 1;49(6):525–528. https://doi.org/10.1093/jjco/hyz022
Kligerman J, Olivatto LO, Lima RA et al (1995) Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx. Am J Surg 170(5):436–439. https://doi.org/10.1016/s0002-9610(99)80324-9
doi: 10.1016/s0002-9610(99)80324-9 pubmed: 7485727
Deganello A, Gitti G, Meccariello G, Parrinello G, Mannelli G, Gallo O (2011) Effectiveness and pitfalls of elective neck dissection in N0 laryngeal cancer. Acta Otorhinolaryngol Ital 31(4):216–221
pubmed: 22058599 pmcid: 3203726
Sharbel DD, Abkemeier M, Groves MW, Albergotti WG, Byrd JK, Reyes-Gelves C (2021) Occult Metastasis in laryngeal squamous cell carcinoma: a systematic review and Meta-Analysis. Ann Otol Rhinol Laryngol. 130(1):67–77. https://doi.org/10.1177/0003489420937744
Yovchev I, Konsulov S, Pazardzhikliev D (2003) Regional recurrences of N0 primary laryngeal cancer: a retrospective study of fiveyear period. J BUON 8(3):253–255
pubmed: 17472259
Saito Y, Yoshimoto S, Kitayama M et al (2023) Elective neck dissection for T3-T4N0 laryngeal carcinoma: evidence from Japan’s National Head and Neck Cancer Registry. Int J Clin Oncol 28(2):209–220. https://doi.org/10.1007/s10147-022-02275-w
doi: 10.1007/s10147-022-02275-w pubmed: 36436179
Ampil F, Nathan CA, Lian T, Baluna R, Milligan E, Caldito G (2014) Postoperative management in laryngeal cancer with subglottic extension and histologically negative nodes: which patients need adjuvant radiotherapy? Ear Nose Throat J 93(8):354–360. https://doi.org/10.1177/014556131409300814
doi: 10.1177/014556131409300814 pubmed: 25181665
Farlow JL, Birkeland AC, Rosko AJ et al (2019) Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy. Ann Surg Oncol 26:2542–2548
doi: 10.1245/s10434-019-07270-6 pubmed: 30830535 pmcid: 6612310
Russi EG, Sanguineti G, Chiesa F et al (2013) Is there a role for postoperative radiotherapy following open partial laryngectomy when prognostic factors on the pathological specimen are unfavourable? A survey of head and neck surgical/radiation oncologists. Acta Otorhinolaryngol Ital 33(5):311–319
pubmed: 24227896 pmcid: 3825044
Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA (2007) Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69(3):751–760. https://doi.org/10.1016/j.ijrobp.2007.04.021
doi: 10.1016/j.ijrobp.2007.04.021 pubmed: 17560735
Barnett GC, West CML, Dunning AM et al (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9(2):134–142. https://doi.org/10.1038/nrc2587
doi: 10.1038/nrc2587 pubmed: 19148183 pmcid: 2670578
Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol off J Am Soc Clin Oncol 26(22):3770–3776. https://doi.org/10.1200/JCO.2007.14.6647
doi: 10.1200/JCO.2007.14.6647
Garibaldi E, Bresciani S, Airaldi C et al (2009) Radiotherapy after partial laryngectomy: an analysis of 36 cases and a proposal to optimize radiotherapy. Tumori 95:198–206
doi: 10.1177/030089160909500211 pubmed: 19579866
Spriano G, Antognoni P, Sanguineti G et al (2000) Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy. Am J Otolaryngol 21:14–21
doi: 10.1016/S0196-0709(00)80119-2 pubmed: 10668672
Laccourreye O, Hans S, Borzog-Grayeli A, Maulard-Durdux C, Brasnu D, Housset M (2000) Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: a long-term evaluation. Otolaryngol Head Neck Surg 122(5):752–757. https://doi.org/10.1016/S0194-5998(00)70210-5
doi: 10.1016/S0194-5998(00)70210-5 pubmed: 10793360
Alterio D, Ansarin M, Jereczek-Fossa BA et al (2013) What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long-term outcome for partial laryngectomy followed by radiotherapy in 32 patients. Tumori. 99(6):667 – 75. https://doi.org/10.1177/030089161309900605 . PMID: 24503789
Mattioli F, Serafini E, Lo Manto A et al (2023) The role of adjuvant therapy in pT4N0 laryngectomized patients: multicentric observational study. Head Neck 45(1):197–206. https://doi.org/10.1002/hed.27225
doi: 10.1002/hed.27225 pubmed: 36250285

Auteurs

Andy Bertolin (A)

Otolaryngology Unit, Vittorio Veneto Hospital, via Forlanini 71, Vittorio Veneto, Treviso, Italy.

Elisa Laura (E)

Otolaryngology Unit, Vittorio Veneto Hospital, via Forlanini 71, Vittorio Veneto, Treviso, Italy.

Isida Cena (I)

Otolaryngology Unit, Vittorio Veneto Hospital, via Forlanini 71, Vittorio Veneto, Treviso, Italy.

Chiara Varago (C)

Otolaryngology Unit, Vittorio Veneto Hospital, via Forlanini 71, Vittorio Veneto, Treviso, Italy.

Alessandra Di Chicco (A)

Otolaryngology Unit, Head-Neck Surgery Section, Neuroscience Department, Padova University, Padova, Italy.

Leonardo Franz (L)

Phoniatrics and Audiology Section, Neuroscience Department, Padova University, Padova, Italy.

Michelangelo Salemi (M)

Medical Direction Unit, Vittorio Veneto Hospital, Treviso, Italy.

Giovanni Succo (G)

Otorhinolaryngology Unit, San Giovanni Bosco Hospital, Turin, 10154, Italy.

Piero Nicolai (P)

Otolaryngology Unit, Head-Neck Surgery Section, Neuroscience Department, Padova University, Padova, Italy.

Marco Lionello (M)

Otolaryngology Unit, Vittorio Veneto Hospital, via Forlanini 71, Vittorio Veneto, Treviso, Italy. marco.lionello@aulss2.veneto.it.

Classifications MeSH